FINWIRES · TerminalLIVE
FINWIRES

Weekly Mortgage Applications Rise as Rates Fall, MBA Says

-- Mortgage applications in the US increased last week as rates fell, with a "resilient" labor market supporting housing demand despite the macro uncertainty, the Mortgage Bankers Association said Wednesday.

The market composite index, which measures loan application volume, rose 7.9% for the week through Friday on a seasonally adjusted basis. Without adjustment, the index increased 9%.

"Mortgage rates declined last week as financial markets responded positively to the Middle East ceasefire and the lower trend in oil prices," said Mike Fratanton, the MBA's chief economist. "Despite the geopolitical uncertainty, housing demand is being supported by a still resilient job market, and homebuyers are experiencing a buyer's market in most of the country given the higher levels of inventory relative to last year."

The average interest rate for 30-year fixed mortgages with conforming loan balances of $832,750 or less fell to 6.35% from 6.42% a week ago. For loan balances higher than that amount, the rate dropped to 6.43% from 6.48%. For 15-year loans, the rate moved lower to 5.75% from 5.85% week to week, according to the report.

Late Tuesday, US President Donald Trump extended a two-week ceasefire deal with Iran, though he said the naval blockade of Iranian ports would continue.

Fixed-rate mortgages with 30-year terms backed by the Federal Housing Administration fell to 6.10% from 6.14% the week before, the MBA said Wednesday. The share of FHA loans, which are often used by first-time home buyers and can involve smaller down payments, remained unchanged at 18.2% of total applications.

The refinance index moved up 6% on a weekly basis, while the seasonally adjusted purchase index surged 10%, according to the report.

Earlier this week, a survey by Redfin showed that US home sellers outnumbered buyers by a near-record percentage in March.

Related Articles

Sectors

Sector Update: Health Care

Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index decreasing 0.2% and the State Street Health Care Select Sector SPDR ETF (XLV) fractionally lower.The iShares Biotechnology ETF (IBB) fell 1.8%.In corporate news, Grace Therapeutics (GRCE) shares tumbled 48% after it said the US Food and Drug Administration issued a complete response letter for its new drug application for GTx-104, an intravenous formulation of nimodipine for aneurysmal subarachnoid hemorrhage.

$GRCE
Sectors

Sector Update: Consumer

Consumer stocks were mixed late Thursday afternoon, with the State Street Consumer Staples Select Sector SPDR ETF (XLP) rising 1.8% and the State Street Consumer Discretionary Select Sector SPDR ETF (XLY) falling 1%.In corporate news, Comcast (CMCSA) reported higher-than-expected Q1 results as the media and connectivity giant benefited from the Milan Cortina Winter Olympics and Super Bowl LX. Its shares jumped past 8%.

$CMCSA
Australia

Vertiv Raises Outlook After Strong Q1 as Margins Improve, UBS Says

Vertiv Holdings (VRT) posted strong Q1 results and raised its full-year earnings outlook, signaling continued margin expansion and solid growth momentum, UBS Securities said Wednesday in a note.The company lifted its full-year adjusted earnings per share guidance to about $6.35 at the midpoint, 4% above consensus estimates, helped by 2% higher organic sales and an 80-basis-point improvement in adjusted operating margin, UBS said. The updated outlook implies incremental margins of 32%, up from 28% previously, the note said.Q1 operating results came in 10% ahead of expectations, driven largely by stronger margins, while revenue was slightly above estimates, UBS said. Organic sales growth was modestly below elevated expectations, attributed to timing rather than softer demand, the note said.The midpoint of Vertiv's Q2 EPS outlook at $1.40 is below the $1.43 consensus estimate, which may reflect initial conservatism from management, the note said.UBS has a buy rating on Vertiv stock with a price target of $370.Price: $315.79, Change: $+10.65, Percent Change: +3.49%

$VRT